Stocks and Finance

Watson Pharmaceuticals

Watson Pharmaceuticals 5/24/2012

09:37 : Watson Pharmaceuticals ([[WPI]] +2.8%) gains on an upgrade to Outperform ... - Watson Pharmaceuticals (WPI +2.8%) gains on an upgrade to Outperform on valuation at Wells Fargo. Wells says that on deeper analysis, it has higher confidence in the company's ability to hit EPS targets ...
Source : seekingalpha-com

Watson Pharmaceuticals 4/23/2012

15:06 : Watson Pharmaceuticals ([[WPI]] +0.1%) is close to announcing a $5.6B ... - Watson Pharmaceuticals (WPI +0.1%) is close to announcing a $5.6B deal for Actavis by Wednesday, according to sources. The deal is an important oneto Deutsche Bank (DB -3.6%), which was left holding billions ...
Source : seekingalpha-com

Watson Pharmaceuticals 4/4/2012

10:21 : Watson Pharmaceuticals (WPI): We Would Be Buyers - Following a notable pick-up in call volume on the generic sector following GphA (Generic Pharmaceutical Association) that has continued given the widespread speculation around a possible acquisition of European-based Actavis by Watson, Canaccord Genuity ...
Source : forbes-com

Watson Pharmaceuticals 3/2/2012

10:59 : Watson Pharmaceuticals ([[WPI]] -0.3%) confirms that it launched a generic - Watson Pharmaceuticals (WPI -0.3%) confirms that it launched a generic version of Prometrium as part of an agreement with Abbott Laboratories (ABT +0.1%). Over the last 12-month reporting period, ...
Source : seekingalpha-com

Watson Pharmaceuticals 2/10/2012

14:58 : Watson Pharmaceuticals ({{WPI]] -0.2%) faces a lawsuit from Bayer (BAYRY.PK - Watson Pharmaceuticals ({{WPI]] -0.2%) faces a lawsuit from Bayer (BAYRY.PK) over accusations that it violated the drug maker's birth control patents, according to Bloomberg. Post your comment!
Source : seekingalpha-com

Watson Pharmaceuticals 1/24/2012

03:33 : Watson Pharmaceuticals (WPI) agrees to buy Ascent Pharmahealth for A$375M - Watson Pharmaceuticals (WPI) agrees to buy Ascent Pharmahealth for A$375M ($396M), turning Watson into the fifth-largest generic pharmaceuticals firm in Australia and the largest in Singapore, ...
Source : seekingalpha-com

Watson Pharmaceuticals 10/27/2011

11:43 : Forbes Earnings Preview: Watson Pharmaceuticals - Wall Street is expecting higher profit for Watson Pharmaceuticals (WPI) when the company reports its third quarter results on Tuesday, November 1, 2011. The consensus estimate is calling for profit of $1.05 ...
Source : forbes-com

Watson Pharmaceuticals 9/21/2011

08:56 : Piper Jaffray lifts up Watson Pharmaceuticals ([[WPI]] +0.6%) with a reite - Piper Jaffray lifts up Watson Pharmaceuticals (WPI +0.6%) with a reiteration of its Overweight rating. "We continue to believe that visibility on double-digit EPS growth for WPI for at least the next 2-3 years is strong." ...
Source : seekingalpha-com

Watson Pharmaceuticals 7/18/2011

10:17 : Watson Pharmaceuticals With A Healthy Outlook - Watson Pharmaceuticals, Inc. (WPI - Analyst Report) has been riding an incredibly smooth trend higher for most of the last 12 months, recently hitting a new all-time high on strong Q1 results that came in ahead of expectations. ...
Source : forbes-com

Watson Pharmaceuticals 6/3/2011

08:19 : Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Generic ... - JOHANNESBURG, SOUTH AFRICA--(Marketwire - Jun 3, 2011) - www.stockcall.com/ offers investors comprehensive research on the Drugs - Generic industry and has completed analytical research on Mylan Inc. (NASDAQ: MYL) and Watson Pharmaceuticals|Watson ...
Source : marketwire-com
actualidad Watson Pharmaceuticals -


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts